These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16857792

  • 21. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 22. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
    Yasugi E, Horiuchi A, Uemura I, Okuma E, Nakatsu M, Saeki K, Kamisaka Y, Kagechika H, Yasuda K, Yuo A.
    Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735
    [Abstract] [Full Text] [Related]

  • 23. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.
    Lodillinsky C, Umerez MS, Jasnis MA, Casabé A, Sandes E, Eiján AM.
    Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J, Lu H, Huang R, Lin D, Wu X, Lin Q, Wu X, Zheng J, Pan X, Peng J, Song Y, Zhang M, Hou M, Chen F.
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
    Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Takayama M.
    Cancer; 2003 Jan 01; 97(1):79-89. PubMed ID: 12491508
    [Abstract] [Full Text] [Related]

  • 26. Expression of organic cation transporter SLC22A16 in human endometria.
    Sato N, Ito K, Onogawa T, Akahira J, Unno M, Abe T, Niikura H, Yaegashi N.
    Int J Gynecol Pathol; 2007 Jan 01; 26(1):53-60. PubMed ID: 17197897
    [Abstract] [Full Text] [Related]

  • 27. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
    Coyle AT, Kinsella BT.
    Biochem Pharmacol; 2006 Apr 28; 71(9):1308-23. PubMed ID: 16499875
    [Abstract] [Full Text] [Related]

  • 28. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G, Jacob J, Buckendahl AC, Grützmann R, Alldinger I, Sipos B, Klöppel G, Bahra M, Langrehr JM, Neuhaus P, Dietel M, Pilarsky C.
    Clin Cancer Res; 2006 Nov 01; 12(21):6444-51. PubMed ID: 17085658
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
    Zhang CH, Wen ZQ, Li JF, Li CZ, Shi M, Yang GW, Lan SM, Zhu Y, Wang F, Zhang YJ, Wang YY, Zhang H.
    Chin Med J (Engl); 2008 Jan 20; 121(2):166-71. PubMed ID: 18272045
    [Abstract] [Full Text] [Related]

  • 30. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M.
    Anticancer Drugs; 2007 Jan 20; 18(1):65-78. PubMed ID: 17159504
    [Abstract] [Full Text] [Related]

  • 31. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
    Wang ZH, Feng YJ, Su M, Yi XF.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb 20; 42(2):111-5. PubMed ID: 17442186
    [Abstract] [Full Text] [Related]

  • 32. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.
    Pavan L, Tarrade A, Hermouet A, Delouis C, Titeux M, Vidaud M, Thérond P, Evain-Brion D, Fournier T.
    Carcinogenesis; 2003 Aug 20; 24(8):1325-36. PubMed ID: 12807721
    [Abstract] [Full Text] [Related]

  • 33. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May 20; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 34. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D, Jarry A, Mottier S, Toquet C, Masson D, Mosnier JF, Laboisse CL, Denis MG.
    Oncol Rep; 2007 Aug 20; 18(2):489-95. PubMed ID: 17611675
    [Abstract] [Full Text] [Related]

  • 35. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.
    Kuo DY, Mallick S, Shen HJ, DeVictoria C, Jones J, Fields AL, Goldberg GL, Runowicz CD, Horwitz SB.
    Clin Cancer Res; 1996 Dec 20; 2(12):1981-92. PubMed ID: 9816157
    [Abstract] [Full Text] [Related]

  • 36. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G, Li XP, Wang JL, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov 20; 47(11):839-45. PubMed ID: 23302125
    [Abstract] [Full Text] [Related]

  • 37. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A, Herrero A, Cajaraville MP.
    Toxicol In Vitro; 2005 Sep 20; 19(6):725-35. PubMed ID: 15964169
    [Abstract] [Full Text] [Related]

  • 38. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor.
    Matsuzaki Y, Koyama M, Hitomi T, Takaoka Y, Kawanaka M, Sakai T.
    Int J Oncol; 2005 Aug 20; 27(2):497-503. PubMed ID: 16010433
    [Abstract] [Full Text] [Related]

  • 39. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T, Enomoto T, Fujita M, Ueda Y, Miyatake T, Fujiwara K, Miyake T, Kimura T, Yoshino K, Kimura T.
    Gynecol Oncol; 2008 Sep 20; 110(3):439-44. PubMed ID: 18572225
    [Abstract] [Full Text] [Related]

  • 40. [Expression of estrogen receptor-related receptor isoforms in endometrial carcinoma tissues and its clinical significance].
    Gao M, Wei LH, Sun PM, Zhao D, Wang JL, Wang ZQ, Zhao C.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov 20; 40(11):756-60. PubMed ID: 16324250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.